Furthermore, we have recently shown that CAV-1, a tumor promoter sustaining rhabdomyosarcomagenesis (151–153), promotes radioresistance in RMS through increased oxidative stress protection (128) and that RMS surviving to RT more efficiently detoxifies from ROS (109). Here, CAV1 is linked to neoplasm.